U.S. track star Noah Lyles takes bronze in 200-meter, says he tested positive for Covid

U.S. track star Noah Lyles takes bronze in 200-meter, says he tested positive for Covid


Botswana’s Letsile Tebogo, US’ Kenneth Bednarek and US’ Noah Lyles cross the finish line to finish first, second and third respectively in the men’s 200m final of the athletics event at the Paris 2024 Olympic Games at Stade de France in Saint-Denis, north of Paris, on August 8, 2024.

Odd Andersen | AFP | Getty Images

PARIS — Two days after Noah Lyles said he tested positive for Covid, the American sprinter finished third in the 200-meter final at the Paris Olympics, unable to chase down gold medalist Letsile Tebogo of Botswana. 

Lyles ran 19.70 for bronze, behind Tebogo’s 19.46, which earned the first gold medal in Botswana’s history. American Kenny Bednarek earned silver in 19.62.

Following his positive test, Lyles said he moved into a hotel away from the Olympic Village to quarantine himself and arrived for warmups before Wednesday’s semifinal with a mask on. He said he never considered not competing in Thursday’s final and intentionally did not disclose information about his diagnosis.

“You never want to tell your competitors you’re sick,” he said. “Why would you give them an edge over you?”

Lyles, 27, appeared his usual energetic self when he was introduced before the final, jumping and sprinting down the track before getting into his blocks as a sold-out crowd inside Stade de France grew silent. Lyles was running from behind right from the start, looking little like the sprinter who had won 26 consecutive races dating to 2021 until he finished second in Wednesday’s semifinal — also to Tebogo — and had been 38-5 all-time against the seven other sprinters in Thursday’s final. 

At the finish line Lyles collapsed, then gingerly stood while asking for water and sitting back down on the track. He was put into a wheelchair and carted off underneath the stadium. It was a stark contrast to Sunday night, when Lyles won the first Olympic gold medal of his career by winning the 100-meters by five-thousandths of a second and afterward guaranteed that he would win the 200 meters, as well. 

US’ Noah Lyles reacts after competing in the men’s 200m final of the athletics event at the Paris 2024 Olympic Games at Stade de France in Saint-Denis, north of Paris, on August 8, 2024. 

Jewel Samad | AFP | Getty Images

Testing positive for COVID “definitely affected my performance,” Lyles said. “But I mean, to be honest, I’m more proud of myself than anything coming out and get the bronze medal with COVID in three days. It’s been a wild Olympics.”

In a statement, USA Track & Field said that it and the U.S. Olympic committee had adhered to guidelines set by the Centers for Disease Control and the International Olympic Committee to “prioritize his health, the wellbeing of our team, and the safety of fellow competitors.” 

“Our primary commitment is to ensure the safety of Team USA athletes while upholding their right to compete. After a thorough medical evaluation, Noah chose to compete tonight. We respect his decision and will continue to monitor his condition closely.”

Lyles was attempting to become the first man to sweep both sprints at an Olympics since Jamaica’s Usain Bolt in 2016, and the first from the U.S. since Carl Lewis 40 years ago. Earning bronze also ends Lyles’s much-discussed ambition of becoming the first track athlete to win four gold medals at a single Olympics since 1984.

He said he would let USA Track & Field decide whether he should run on the U.S. 4×100-meter relay team that qualified for Friday’s final with the fastest time in preliminaries.



Source

Hims & Hers to offer generic semaglutide in Canada as Novo Nordisk patent lapses
Health

Hims & Hers to offer generic semaglutide in Canada as Novo Nordisk patent lapses

The Hers website arranged on a laptop in New York, US, on Wednesday, Feb. 12, 2025. Gabby Jones | Bloomberg | Getty Images Hims & Hers Health announced Wednesday it will offer generic semaglutide in Canada as Novo Nordisk‘s patent on its branded drugs Ozempic and Wegovy is set to expire in January. “Canada is […]

Read More
Trump threatens to impose up to 200% tariff on pharmaceuticals ‘very soon’
Health

Trump threatens to impose up to 200% tariff on pharmaceuticals ‘very soon’

U.S. President Donald Trump speaks next to Defense Secretary Pete Hegseth during a cabinet meeting at the White House in Washington, D.C., U.S., July 8, 2025. Kevin Lamarque | Reuters President Donald Trump on Tuesday threatened to impose up to 200% tariffs on pharmaceuticals imported into the U.S. “very soon.”  “They’re going to be tariffs […]

Read More
Healthy Returns: Medicaid cuts in Trump’s megabill may affect some drugmakers more than others
Health

Healthy Returns: Medicaid cuts in Trump’s megabill may affect some drugmakers more than others

U.S. President Donald Trump presents a sweeping spending and tax legislation, known as the “One Big Beautiful Bill Act,” after he signed it, at the White House in Washington, D.C., U.S., July 4, 2025. Leah Millis | Reuters A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care […]

Read More